17-hydroxyprogesterone (17-OHP)

17-Hydroxyprogesterone (17-OH progesterone) is a crucial steroid hormone involved in the biosynthesis of glucocorticoids, androgens, and estrogens. It plays a particularly important role in adrenal function and reproductive health. Abnormal levels of 17-OH progesterone can indicate a variety of health issues, most notably Congenital Adrenal Hyperplasia (CAH).
17-OH progesterone is an endogenous progestogen and an intermediate in the biosynthesis of cortisol and androgens. It is produced primarily in:
The adrenal glands
The gonads (ovaries and testes)
It serves as a precursor molecule that undergoes enzymatic conversion by 21-hydroxylase and 11β-hydroxylase enzymes in the adrenal cortex to produce cortisol and aldosterone.
The synthesis pathway:
Cholesterol → Pregnenolone → Progesterone → 17-OH Progesterone → 11-Deoxycortisol → Cortisol
When there's a deficiency in enzymes (e.g., 21-hydroxylase), this pathway is disrupted, leading to the accumulation of 17-OH progesterone and diverted production toward androgens.
Precursor for cortisol, a vital stress hormone
Involved in androgen production
Affects sexual development and function
The most critical clinical role of 17-OH progesterone is its elevation in CAH, a group of genetic disorders affecting adrenal steroid biosynthesis.
“Elevated 17-hydroxyprogesterone levels are a hallmark of 21-hydroxylase deficiency. Early detection through newborn screening can be life-saving.” — Dr. Mary Therese South, MD, Pediatric Endocrinologist, Mayo Clinic
A 17-OH progesterone blood test is primarily used to:
Diagnose CAH in newborns and children
Investigate hirsutism, infertility, or menstrual irregularities
Evaluate adrenal tumours or hyperplasia
Support hormonal investigations in reproductive or endocrine disorders
You can order a progesterone blood test here.
Group | Range (ng/dL) |
---|---|
Newborns (preterm) | 100–5000 |
Newborns (full-term) | 100–2500 |
Children | <100 |
Adult Women (follicular) | 20–100 |
Adult Women (luteal) | 100–500 |
Adult Men | <200 |
Timing: Best collected in the morning when hormone levels are highest.
Fasting: Usually not required.
Special Instructions: For women, testing should ideally occur during the follicular phase (day 3–5) of the menstrual cycle unless otherwise instructed.
Most common cause
Autosomal recessive condition
Enzyme: 21-hydroxylase deficiency in 95% of cases
Leads to cortisol deficiency and androgen excess
Rare adrenal adenomas or carcinomas may secrete excessive 17-OH progesterone
Mild elevations can be observed, but typically not as high as in CAH
“Differentiating PCOS from non-classic CAH is critical in women presenting with hyperandrogenic symptoms. A morning 17-OHP level >200 ng/dL warrants further evaluation with ACTH stimulation testing.” — Dr. Ricardo Azziz, Endocrinologist and PCOS expert
Low levels are typically not concerning unless in the context of:
Adrenal insufficiency (Addison’s disease)
Hypopituitarism
Over-suppression from steroid therapy
Excess androgens due to elevated 17-OHP can disrupt ovulation, causing irregular periods, amenorrhea, or infertility.
Elevated 17-OHP leads to increased production of testosterone and DHEA, contributing to male-pattern hair growth and skin issues.
“In reproductive-aged women, symptoms like hirsutism and acne, especially when paired with irregular cycles, should prompt a hormonal workup including 17-OH progesterone.” — Dr. Andrea Dunaif, MD, Reproductive Endocrinologist
Explore our range of progesterone supplements here.
In men, elevated levels can indicate:
CAH
Testicular adrenal rest tumours (TARTs) in CAH patients
Adrenal disorders
It may also impact fertility due to hormonal imbalances.
When 17-OHP levels are borderline or mildly elevated, an ACTH stimulation test is used to confirm or rule out non-classic CAH.
Procedure:
Baseline blood draw
Administer synthetic ACTH (cosyntropin)
Measure 17-OHP after 60 minutes
Interpretation:
A stimulated level >1500 ng/dL strongly supports non-classic CAH
Glucocorticoid replacement (e.g., hydrocortisone, prednisone)
Mineralocorticoid replacement in salt-wasting forms
Surgical treatment for severe virilisation
Regular monitoring of 17-OHP to guide therapy
Oral contraceptives
Anti-androgens (e.g., spironolactone)
Lifestyle and dietary interventions
Advancements in genetic screening and LC-MS/MS (liquid chromatography-mass spectrometry) testing have improved accuracy.
“With better mass spectrometry-based assays, we can now distinguish between classic and non-classic CAH more reliably, even in borderline cases.” — Dr. William E. Rainey, Professor of Molecular & Integrative Physiology, University of Michigan
Aspect | Details |
---|---|
What it is | A steroid hormone involved in cortisol and androgen production |
Tested for | Diagnosis of CAH, PCOS, adrenal or gonadal disorders |
High Levels | Suggest CAH, adrenal tumours, or PCOS |
Low Levels | May suggest adrenal insufficiency or over-suppression by medication |
Treatment | Hormonal therapy, glucocorticoids, surgical intervention (if needed) |
Important in | Newborn screening, reproductive health, endocrine disorders |
Speiser PW, White PC. "Congenital Adrenal Hyperplasia." N Engl J Med. 2003;349(8):776-788.
Azziz R. "The Evaluation and Management of Hirsutism." Obstet Gynecol. 2003;101(5 Pt 1):995-1007.
New MI. "An update on congenital adrenal hyperplasia." Curr Opin Endocrinol Diabetes Obes. 2012;19(3):166–170.
Trapp CM, Oberfield SE. "Diagnosis and management of congenital adrenal hyperplasia." Curr Opin Pediatr. 2012;24(4):527–533.
Plus get the inside scoop on our latest content and updates in our monthly newsletter.